BRA

Bender Robert & Associates Portfolio holdings

AUM $448M
This Quarter Return
-1.18%
1 Year Return
+20.39%
3 Year Return
5 Year Return
10 Year Return
AUM
$258M
AUM Growth
+$258M
Cap. Flow
+$17.7M
Cap. Flow %
6.86%
Top 10 Hldgs %
68%
Holding
56
New
1
Increased
27
Reduced
10
Closed
2

Sector Composition

1 Technology 37.42%
2 Consumer Discretionary 28.28%
3 Healthcare 21.48%
4 Communication Services 9.88%
5 Utilities 1.32%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GILD icon
26
Gilead Sciences
GILD
$140B
$2.24M 0.87%
36,346
-1,254
-3% -$77.4K
BMY icon
27
Bristol-Myers Squibb
BMY
$96.5B
$1.99M 0.77%
27,947
+2,885
+12% +$205K
AMD icon
28
Advanced Micro Devices
AMD
$263B
$1.91M 0.74%
30,180
+10,892
+56% +$690K
PFE icon
29
Pfizer
PFE
$142B
$903K 0.35%
20,630
+1,450
+8% +$63.5K
CTSH icon
30
Cognizant
CTSH
$35.1B
$902K 0.35%
15,711
-3,187
-17% -$183K
JNJ icon
31
Johnson & Johnson
JNJ
$429B
$900K 0.35%
5,507
+400
+8% +$65.4K
COST icon
32
Costco
COST
$416B
$889K 0.34%
1,883
ABT icon
33
Abbott
ABT
$229B
$869K 0.34%
8,986
+280
+3% +$27.1K
BCRX icon
34
BioCryst Pharmaceuticals
BCRX
$1.74B
$864K 0.33%
68,600
PAYX icon
35
Paychex
PAYX
$49B
$802K 0.31%
7,150
-100
-1% -$11.2K
NSC icon
36
Norfolk Southern
NSC
$62.4B
$742K 0.29%
3,541
+100
+3% +$21K
MRK icon
37
Merck
MRK
$214B
$740K 0.29%
8,592
+880
+11% +$75.8K
DE icon
38
Deere & Co
DE
$129B
$521K 0.2%
1,561
PANW icon
39
Palo Alto Networks
PANW
$127B
$494K 0.19%
+3,015
New +$494K
NUE icon
40
Nucor
NUE
$33.6B
$448K 0.17%
4,190
-25
-0.6% -$2.67K
JPM icon
41
JPMorgan Chase
JPM
$824B
$432K 0.17%
4,134
BA icon
42
Boeing
BA
$179B
$356K 0.14%
2,940
URGN icon
43
UroGen Pharma
URGN
$904M
$342K 0.13%
41,131
TGT icon
44
Target
TGT
$42B
$309K 0.12%
2,080
-20
-1% -$2.97K
CAT icon
45
Caterpillar
CAT
$195B
$265K 0.1%
1,617
DUK icon
46
Duke Energy
DUK
$94.8B
$244K 0.09%
2,626
TROW icon
47
T Rowe Price
TROW
$23.2B
$224K 0.09%
2,135
EOLS icon
48
Evolus
EOLS
$485M
$202K 0.08%
25,070
BBIG
49
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$74K 0.03%
80,000
CLVS
50
DELISTED
Clovis Oncology, Inc.
CLVS
$60K 0.02%
50,000